Outlook Therapeutics Inc (OTLK)
7.53
-0.47
(-5.88%)
USD |
NASDAQ |
May 23, 16:00
7.50
-0.03
(-0.40%)
After-Hours: 20:00
Outlook Therapeutics Shareholders Equity (Quarterly): -134.24M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -134.24M |
| December 31, 2023 | -24.34M |
| September 30, 2023 | -14.44M |
| June 30, 2023 | -5.503M |
| March 31, 2023 | 10.49M |
| December 31, 2022 | 15.76M |
| September 30, 2022 | 8.737M |
| June 30, 2022 | 20.08M |
| March 31, 2022 | 35.96M |
| December 31, 2021 | 48.82M |
| September 30, 2021 | 4.607M |
| June 30, 2021 | 12.75M |
| March 31, 2021 | 20.65M |
| December 31, 2020 | -10.48M |
| September 30, 2020 | 2.826M |
| June 30, 2020 | 10.97M |
| March 31, 2020 | -20.52M |
| December 31, 2019 | -25.41M |
| Date | Value |
|---|---|
| September 30, 2019 | -10.77M |
| June 30, 2019 | -1.358M |
| March 31, 2019 | -23.05M |
| December 31, 2018 | -21.47M |
| September 30, 2018 | -20.81M |
| June 30, 2018 | -9.265M |
| March 31, 2018 | -15.27M |
| December 31, 2017 | -7.898M |
| September 30, 2017 | -30.73M |
| June 30, 2017 | -28.94M |
| March 31, 2017 | -26.85M |
| December 31, 2016 | -21.83M |
| September 30, 2016 | -5.173M |
| June 30, 2016 | 1.563M |
| March 31, 2016 | -20.47M |
| December 31, 2015 | -12.02M |
| September 30, 2015 | -28.60M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-134.24M
Minimum
Mar 2024
48.82M
Maximum
Dec 2021
-2.770M
Average
3.717M
Median
Shareholders Equity (Quarterly) Benchmarks
| Cutera Inc | -192.56M |
| Actinium Pharmaceuticals Inc | 43.86M |
| GT Biopharma Inc | 5.312M |
| Karyopharm Therapeutics Inc | -168.96M |
| Marinus Pharmaceuticals Inc | -16.43M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 59.03M |
| Total Liabilities (Quarterly) | 193.26M |